Prognostic factors analysis in EGFR mutation-positive non-small cell lung cancer with brain metastases treated with whole brain-radiotherapy and EGFR-tyrosine kinase inhibitors.
about
Prognostic factors analysis in EGFR mutation-positive non-small cell lung cancer with brain metastases treated with whole brain-radiotherapy and EGFR-tyrosine kinase inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prognostic factors analysis in ...... FR-tyrosine kinase inhibitors.
@ast
Prognostic factors analysis in ...... FR-tyrosine kinase inhibitors.
@en
type
label
Prognostic factors analysis in ...... FR-tyrosine kinase inhibitors.
@ast
Prognostic factors analysis in ...... FR-tyrosine kinase inhibitors.
@en
prefLabel
Prognostic factors analysis in ...... FR-tyrosine kinase inhibitors.
@ast
Prognostic factors analysis in ...... FR-tyrosine kinase inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Prognostic factors analysis in ...... FR-tyrosine kinase inhibitors.
@en
P2093
Changlin Zou
Hangping Wei
Huifang Li
Ruifang Lin
P2860
P304
P356
10.3892/OL.2016.4163
P577
2016-01-29T00:00:00Z